Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery

Clinical trial NCT06030804 · RECRUITING

Trial details

NCT number: NCT06030804
Sponsor: Peking University First Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Elderly Cancer Surgery Dexmedetomidine Long-Term Survivors

Start date: 2023-09-12
Primary completion: 2025-09-01
Enrollment: 4532

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.